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Lipid raftsse closely related viruses of man and animal, including herpes simplex virus,
varicella-zoster virus and pseudorabies virus (PRV). Here, using methyl-beta-cyclodextrin and ﬂuorescently
tagged PRV, we directly show that depletion of cholesterol from the plasma membrane of host cells
signiﬁcantly reduces PRV entry. Cholesterol depletion did not reduce PRV attachment, but stalled virus
particles at the plasma membrane before penetration of the cell. Cholesterol depletion results in
destabilization of lipid raft microdomains in the plasma membrane, which have been shown before to be
involved in efﬁcient entry of different viruses. A signiﬁcant fraction of PRV virions appears to localize
juxtaposed to GM1, a lipid raft marker, during entry. Together, these data indicate that cholesterol and
possibly cholesterol-rich lipid rafts may be important during PRV entry.
© 2008 Elsevier Inc. All rights reserved.IntroductionThe alphaherpesvirus subfamily of the herpesviruses consists of
closely related members, including herpes simplex virus (HSV), the
porcine pseudorabies virus (PRV), varicella-zoster virus (VZV), bovine
herpesvirus type 1 (BoHV1) and the equine herpesvirus type 1 (EHV1).
PRV is often used as a model for this subfamily to study general aspects
of alphaherpesvirus replication and spread (Pomeranz et al., 2005). The
PRV virion consists of a core with the linear double stranded DNA
genome, an icosahedral capsid, a largely amorphous proteinmass called
the tegument and the envelope with embedded, often glycosylated
envelope proteins. As alphaherpesviruses are large viruses with a com-
plex virion structure, they use the cellular machinery for different
aspects of their replication cycle.
Cholesterol represents one of the key constituents of small, dynamic,
sterol- and sphingolipid-enriched domains on the plasma membrane
which are called lipid rafts and which compartmentalize cellular pro-
cesses (Pike, 2006). Removal of cholesterol from the plasmamembrane
leads to loss of lipid raft functionality. This approach is widely used
to determine a possible role of lipid rafts in different processes. Many
viruses, such as human immunodeﬁciency virus (HIV) (Viard et al.,
2002), severe acute respiratory syndrome-coronavirus (SARS) (Li et al.,
2007), murine coronavirus (Choi et al., 2005), poliovirus (Danthi andDesplanques),
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l rights reserved.Chow, 2004), human herpesvirus 6 (Huang et al., 2006), vaccinia virus
(Chung et al., 2005), and foot-and-mouth disease virus (Martin-Acebes
et al., 2007) have been reported to depend on plasma membrane cho-
lesterol or,more speciﬁcally, lipid rafts for efﬁcient entry. However, there
are only a few indications in literature about a possible role for cho-
lesterol and/or lipid rafts in alphaherpesvirus entry. A role for lipid rafts
during alphaherpesvirus infection has been suggested based on an
association of the herpes simplex virus 1 envelope protein gB, but not
the envelope glycoproteins gD, gC and gH, with lipid rafts during entry
(Bender et al., 2003). It was also reported thatHSV entrywas suppressed
after cholesterol depletion or chelation (Bender et al., 2003) and that
infectivity of VZVwas sensitive to the same treatment (Hambleton et al.,
2007), indicating a role for cholesterol during the early stages of al-
phaherpesvirus infections. As in many other studies, these reports
determined an effect of cholesterol depletion on virus entry byassessing
immediate-early gene expression (HSV) and infectious foci formation
(VZV), and therefore do not completely discriminate between effects of
cholesterol depletion on different post-attachment stages of entry such
as penetration, capsid transport to the nucleus, genome deposition in
the nucleus, and onset of viral gene expression. The aim of the current
study was to assess directly the role of plasma membrane cholesterol
during alphaherpesvirus entry.
Using the porcine alphaherpesvirus pseudorabies virus (PRV), we
determined if and when there is a role for cholesterol and/or lipid rafts
during the different steps of alphaherpesvirus entry (attachment,
penetration, transport to the nucleus) by directly assessing the effect
of depletion of cholesterol in the host cell plasma membrane on PRV
entry and by assessing whether or not PRV virions co-localize with the
lipid raft marker GM1 upon attachment to host cells.
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Cholesterol depletion reduces entry of PRV
Entry of PRV in host cells was assessed at 2 h p.i. with ﬂuo-
rescently tagged PRV (VP26 capsid protein fused to GFP) by cal-
culating the number of perinuclear virions, i.e. virions that entered
the cell. To assess the importance of cholesterol during PRV entry,
plasma membrane cholesterol was removed from cells in adhesion
by 10 mM methyl-beta-cyclodextrin (MBCD) treatment and was
either or not replenished by addition of 5 or 100 μg/ml cholesterol.
Cholesterol measurement with the Amplex® Red Cholesterol assayFig. 1. Cholesterol depletion reduces PRV entry. Entry of PRV was analyzed in untreated cont
5 μg/ml cholesterol (MBCD, 5 μg/ml chol) or 100 μg/ml cholesterol (MBCD, 100 μg/ml chol). (
Green signal: VP26-GFP PRV virus particles; red signal: biotinylated anti-PRV antibody, stain
area of the cell are shown. Scale bar: 10 μm. Upper panel: overlay of green and red signal; low
different treatments. (C) Quantitative analysis of PRV entry. At least 60 cells were count
perinuclear virions in the analyzed area of the cell. ⁎ indicates signiﬁcant differences com
envelope protein (Texas Red). Double-positive punctae are indicated with arrows. Scale bar:kit revealed that MBCD treatment removed cholesterol efﬁciently
and that the cholesterol content was restored by addition of cho-
lesterol (Fig. 1B). Entry was analyzed quantitatively and entry of PRV
was reduced signiﬁcantly after MBCD treatment: 60% reduction of
the number of perinuclear virions relative to control cells (Figs. 1A
and C). Repleting cellular cholesterol after MBCD treatment by ad-
dition of cholesterol restored this reduction: 33% reduction relative
to control cells after addition of 5 μg/ml cholesterol and 10% re-
duction relative to control cells after addition of 100 μg/ml
cholesterol (Figs. 1A and C). This indicates that plasma membrane
cholesterol plays an important role during entry of PRV particles in
the host cell.rol cells (control), MBCD-treated cells (MBCD) and MBCD-treated cells replenished with
A) Confocal images of PRV entry (2 h p.i.) in cells in adhesion after different treatments.
ed with Streptavidin-Texas Red. Maximum projections of the sections in the 1 μm thick
er panel: green signal. (B) Cholesterol content of the cells, relative to control cells, after
ed per treatment. X-axis: treatment; Y-axis: geometric mean of the total number of
pared to the control at the 0.05 level. (D) VP26-GFP PRV inoculum, stained for the gB
 1 μm.
Fig. 2. Cholesterol depletion stalls virus particles at the plasma membrane. Confocal
images of PRV entry in SK cells in suspension. Maximum projections of the sections in
the 1 μm thick area of the cell are shown. Upper panel: untreated control cells, 2 h p.i. at
37 °C; middle panel: MBCD-treated cells, 2 h p.i. at 37 °C; lower panel: untreated control
cells, 2 h p.i. at 4 °C. Green signal: VP26-GFP PRV virus particles; Texas Red staining:
cortical actin. Scale bar: 10 μm.
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composition of the viral inoculum was analyzed by immunoﬂuores-
cence (Fig.1D). All observed GFP punctae in the inoculumwere found to
co-label for gB and therefore represent enveloped virus particles. Hence,
all GFP detected in the current assay represent virus particles. Punctae
single positive for gB and of similar size as virus particles were also
frequently observed. These punctae may perhaps represent capsid-less
L-particles, which have been described before for several alphaherpes-
viruses (Aleman et al., 2003; Subak-Sharpe and Dargan, 1998).
Cholesterol depletion does not reduce attachment of PRV, but stalls virus
particles at the plasma membrane
Entry of alphaherpesviruses in host cells can be subdivided in three
steps: attachment to the host cell, penetration, and transport of the
capsid to the nucleus along microtubules.Fig. 3. Cholesterol depletion does not reduce attachment of PRV. Assessment of VP26-GFP
attachment to SK cells in a ﬂow cytometric assay. Grey line with grey ﬁll: mock infected
cells (4 °C); black line: control cells 2 h p.i. (4 °C); black dashed line:MBCD-treated cells 2 h
p.i. (4 °C); grey line without ﬁll: cells pretreated with heparin, 2 h p.i. (4 °C).To further determinewhich step in entry is cholesterol-dependent,
the total number of virions and the percentage of plasma membrane-
associated and perinuclear virions were determined in MBCD-treatedFig. 4. Stalled virions at the plasmamembrane afterMBCD treatment can be removed by
trypsin treatment. (A and B) Confocal images of untreated control cells 2 h p.i. at 37 °C,
MBCD-treated cells 2 h p.i. at 37 °C and control cells 2 h p.i. at 4 °C. Green signal: VP26-
GFP PRVvirus particles; Texas Red staining: cortical actin. Scale bar: 10 μm. (A)No trypsin
treatment after entry. (B) Trypsin treatment after entry. (C) Quantitative analysis:
number of plasma membrane-associated or perinuclear virions counted in the analyzed
1 μm thick area of 12 MBCD-treated cells, without or with trypsin treatment after entry.
342 A.S. Desplanques et al. / Virology 376 (2008) 339–345cells and untreated control cells in suspension (Fig. 2). This suspension
assay facilitated analysis and allowed ﬂow cytometric measurements.
MBCD treatment caused a similar reduction in entry in cells in sus-
pension as observed in cells in adhesion: 18±4 perinuclear virions in
control cells versus 9±3 in MBCD-treated cells.
MBCD treatment did not affect the total number of virions associated
with a host cell (21±3, versus 24±4 in control cells). This indicates
that cholesterol depletion does not affect virion attachment. A ﬂow
cytometric assaywas performed to conﬁrm that virus attachment to the
host cell is not affected by MBCD treatment. The ﬂow cytometric assay
wasperformed at4 °C, a temperature atwhich thevirus can attach to the
host cell, but does not penetrate cells. Again, MBCD treatment did not
reduce attachment of PRV to the host cell (Fig. 3). As an extra control,
pretreating the cells with 250 μg/ml heparin was found to reduce the
ﬂuorescence signal to the level of the mock signal, indicating that at-
tachment is speciﬁc.
Entry assays in suspension also revealed that a much higher
percentage (59±8%) of virions were plasma membrane-associated in
MBCD-treated cells compared to control cells (30±6%) (Fig. 2). Together,
these data indicate that cholesterol depletion does not reduce attach-
ment of PRV to the host cell, but that it stalls virus particles at or
immediately underneath the plasma membrane. This indicates that
cholesterol depletion suppresses viral entry at the level of penetration,
or at the level of initiation of transport of capsids to the nucleus.
Cholesterol depletion reduces penetration of PRV
The confocal and ﬂow cytometric assays described above cannot
fully discriminate whether MBCD treatment stalls virus particles after
attachment but before penetration, or after attachment and penetra-
tion, but before engagement of microtubule-mediated transport to the
nucleus. To further determine whether or not the virions that are
stalled at the plasma membrane after MBCD treatment had passed
this membrane, we used a trypsin-based assay. Trypsin-based assays
have been used before to remove non-internalized particles from the
plasma membrane (Nishi and Saigo, 2007). In contrast to virions that
have passed the plasma membrane, virions that are bound to the
plasma membrane, but did not pass it, are removed by a trypsin
treatment of the cells. Trypsin treatment efﬁciently removed particles
from the plasma membrane in a control experiment when cells had
been inoculated at 4 °C (Figs. 4A and B, lower panels). Trypsin
treatment also removed almost all plasma membrane-associated
virions in MBCD-treated cells (Figs. 4A and B, middle panels and C). As
expected, the number of perinuclear virions in MBCD-treated cells
was not affected by the trypsin treatment (Fig. 4C). This indicates that
MBCD treatment suppresses penetration of PRV in host cells.
A signiﬁcant fraction of PRV appears to localize juxtaposed to the lipid
raft marker GM1 during entry
Cholesterol is a major constituent of lipid rafts. Because of their
dependence on cholesterol for efﬁcient entry, different viruses have
been suggested to use lipid rafts as entry platforms (Nayak and Hui,Fig. 5. A signiﬁcant fraction of virions appears to localize juxtaposed to GM1, a lipid raft
marker, during entry. (A) Confocal images of the top of SK cells, 5 min p.i. with VP26-GFP
PRV (green signal), stained for the lipid raft marker GM1 (Texas Red staining). Scale bar:
10 μm. (B) Same as in A, but GM1 was patched before virus addition. Upper 2 panels
show virus localization versus GM1 staining at 5 min p.i., while the lower 2 panels show
an irrelevant merge of the same virions with a patched GM1 image of another cell.
Arrows indicate juxtaposed localization of virus, characterized by a small overlap of
red and green signals. Closed arrowheads show full co-localization, open arrowheads
show lack of co-localization. (C) Percentage of virions scored as ‘co-localized with’,
‘juxtaposed to’ and ‘not associated with’ GM1 patches for real images (cfr. B, upper
panels) and for control images (cfr. B, lower panels). ⁎ indicates that the difference
between real images and control images for this position relative to GM1 is signiﬁcant at
the 0.05 level.2004; Ono and Freed, 2005; Rawat et al., 2003). However, only for a
few viruses, such as HIV and vaccinia virus, a direct role for lipid rafts
during viral entry has been shown by co-localization of viral proteins
or virus receptors with raft markers during entry (Chung et al., 2005;
Popik and Alce, 2004; Popik et al., 2002). We assessed whether there
are direct indications for a role for lipid raft microdomains during
entry of PRV by analyzing whether or not virions co-localize with the
lipid raft marker GM1 (Harder et al., 1998) during entry.
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show a random distribution either. A signiﬁcant fraction of virus
particles appeared to localize juxtaposed to GM1: there was a small
overlap of ﬂuorescent signal between virus particle and GM1 signal
(Fig. 5A). Onlyaminority of particleswas found to fully co-localizewith
spots of GM1 staining and only a minority of particles was found not
to associate at all with spots of GM1 staining. A similar juxtaposed
localization of PRV with GM1 was observed in live cells that were not
ﬁxed (data not shown). However, GM1 covered a very large fraction of
the cell surface, which is in agreementwith other ﬁndings (Kenworthy
et al., 2000). Since the total lipid raft area constituted such a large
fraction of the cell surface, an additional experiment was set up to
exclude the possibility that the frequently observed juxtaposed
localization of PRV with lipid rafts was a chance effect. To this end,
lipid rafts were aggregated in larger clusters (patches) as described
before (Harder et al., 1998), before the addition of virus. Again, a
signiﬁcant fraction of PRV virions appeared to localize juxtaposed to
clustered GM1 (Figs. 5B, upper panels and C). The patching process did
not affect the entry efﬁciency of the virus (data not shown). As an extra,
blind control, unrelated images of PRV virions and patched GM1 were
merged and virion localization was scored as before, resulting in
signiﬁcantly less juxtaposed localization of virions with GM1 (30±8%
versus 56±7% in real images, P value=0.000) and signiﬁcantly more
virions that were not associated with GM1 (45±9% versus 30±6% in
real images, P value=0.008) (Figs. 5B, lower panels and C). In con-
clusion, a signiﬁcant fraction of PRV appears to localize juxtaposed to
the lipid raft marker GM1 during entry.
Discussion
Removal of plasma membrane cholesterol with the cyclodextrin
MBCD was found to signiﬁcantly reduce PRV entry. Cholesterol de-
pletion did not reduce attachment, but stalled virus particles at the
plasma membrane before penetration of the cell. This indicates that
plasma membrane cholesterol is important for PRV to cross the plasma
membrane efﬁciently. Moreover, a signiﬁcant fraction of PRV appeared
to localize juxtaposed to the lipid raft marker GM1 during entry. This
further indicates that lipid rafts can be involved in PRV entry.
Cholesterol depletion by cyclodextrin treatment has been used
before to evaluate the importance of plasma membrane cholesterol
and lipid rafts during entry of viruses. However, the effect of this
treatment on entry is most often not evaluated directly, but by the
assessment of the expression of a reporter gene at several hours post-
inoculation (Bender et al., 2003; Chung et al., 2005), by assessment of
virus production and amount of viral DNA/RNA in the cells (Choi et al.,
2005; Danthi and Chow, 2004; Li et al., 2007), or by the assessment of
infectious foci formation (Hambleton et al., 2007). The observed effect
of cyclodextrin is then often attributed to an effect on entry by
comparing the effect on cells that were pretreated and cells that were
treated at the post-entry stage (Choi et al., 2005; Chung et al., 2005;
Danthi and Chow, 2004; Hambleton et al., 2007; Li et al., 2007). The
current study evaluated the role of cholesterol during entry of the
alphaherpesvirus PRV in a direct manner: ﬂuorescently tagged virus
particles that entered the cell at 2 h p.i. were quantiﬁed. This allowed
us to conclude with great certainty that the observed effect of cho-
lesterol depletion is due to hampered viral entry and not to a further
step in viral infection. The used technique also allowed us to dis-
tinguish between different stages of entry: attachment, penetration
and capsid transport to the nucleus. Flow cytometric analysis, de-
termination of virion localization and virus sensitivity to trypsin
treatment revealed that the stage of entry affected by MBCD is not
attachment to the host cell, but penetration of the plasma membrane.
Importance of cholesterol and/or lipid rafts during viral entry has
been related to different aspects of the viral entry process. Lipid rafts
could create a favourable environment around target membrane re-
ceptors, facilitating oligomerization of (co)receptors or recognition of(co)receptors by the virus (Burger et al., 2000; Viard et al., 2002).
Another explanation may be that the signal transduction molecules
that are particularly concentrated in lipid rafts (Brown, 2006; Brown
and London, 1998, 2000; Dykstra et al., 2003; Helms and Zurzolo,
2004; Simons and Toomre, 2000) facilitate speciﬁc steps in viral entry,
such as penetration or transport of the capsid to the nucleus. E.g.,
during human herpesvirus 8-entry, lipid rafts have been suggested to
be important for modiﬁcation of signalling molecules, microtubule
dynamics and nuclear delivery, but are dispensable for binding and
penetration (Raghu et al., 2007). The importance of lipid rafts can also
be due to the requirement for the speciﬁc classes of lipids that associate
with lipid rafts: cholesterol but also sphingolipids. The concept of lipid
recognition by certain proteins might be an important factor in viral
entry (Teissier and Pecheur, 2007). During retroviral entry, speciﬁc
lipids have an apparent role in conformational changes leading to the
proper exposure of the fusion peptide toward the target membrane
(Alfsen and Bomsel, 2002; Chazal and Gerlier, 2003). As membrane
curvature mainly depends on the molecular shape of lipids, lipids also
play a key role in the membrane deformation that is required for
penetration of the plasma membrane (Teissier and Pecheur, 2007).
Our observation that a signiﬁcant fraction of PRV appears to localize
juxtaposed to GM1, a lipid raft marker, during entry may suggest a
weak or partial raft association that facilitates penetration. Such a
weak or partial interactionwith rafts is in agreement with the ﬁndings
of Bender et al. (2003) for HSV (Bender et al., 2003). Using ﬂotation
assays, these authors found that the viral glycoprotein gB, but not gD,
gC, gH nor the HSV receptors HVEM and nectin associates with lipid
rafts during entry. This interaction ismediated by the ectodomain of gB
(Bender et al., 2003). The authors hypothesized that a cellular gB
receptor is enriched in rafts and that the size of the alphaherpesvirus
envelope would allow the virion to interact simultaneously with both
raft and nonraft domains during attachment. Our observation that a
signiﬁcant fraction of PRV appears to localize juxtaposed to the lipid
raftmarkerGM1during entry is in linewith such a partial or peripheral
lipid raft association of alphaherpesviruses during entry. Perhaps, the
periphery of lipid rafts, which forms the boundary between the
cholesterol-rich rigid raft membrane and themore ﬂuid phospholipid-
rich plasmamembrane (El Kirat andMorandat, 2007), may provide the
most beneﬁcial environment for penetration of the host cell. It is also
possible that the weak or partial association of alphaherpesviruses
with rafts during entry affects raft-associated signalling cascades,
which may be involved in subsequent penetration. Although the
current study points to an important role of cholesterol in PRV pen-
etration and indicates a partial association of PRV with lipid rafts
during entry, further research will be needed to fully clarify the exact
physical role of lipid rafts and cholesterol during alphaherpesvirus
entry.
In conclusion, we found that efﬁcient penetration of the host cell
by PRV requires plasma membrane cholesterol and that a signiﬁcant
fraction of PRV particles appears to localize juxtaposed to the lipid
raft marker GM1 during entry. This may open new insights in the




Porcine biotinylated polyclonal anti-PRV antibodies were prepared
from anti-PRV hyperimmune serum (Nauwynck and Pensaert, 1995)
according to the manufacturer's instructions (Amersham Interna-
tional mIc, Buckinghamshire, UK) and were diluted 1/20. Mouse
monoclonal antibody against gB (1C11) was described earlier and was
used at a dilution 1/100 (Nauwynck and Pensaert, 1995). The Amplex®
Red Cholesterol Assay Kit, Streptavidin-Texas Red (used 1/50), goat-
anti-mouse Texas Red (used 1/100) and Texas Red-X Phalloidin (used
344 A.S. Desplanques et al. / Virology 376 (2008) 339–3451/100) were purchased from Invitrogen (Molecular Probes, Eugene,
Or.). Methyl-β-cyclodextrin (MBCD), water-soluble cholesterol, Triton
X-100, heparin sodium salt from porcine intestinal mucosa, trypsin
from porcine pancreas (stock solution: 2.5% in PBS) and biotinylated
cholera toxin B subunit (stock solution of 1 mg/ml in ultra pure water,
used 1/100) were purchased from Sigma (Sigma Chemical Co., St Louis,
Mo.). Ethylenediaminetetraacetetic acid disodiumsalt (EDTA, stock
solution 2%w/v in PBS)was purchased fromNormapur (Fontenay sous
bois, France).
Virus
The ﬂuorescent VP26-GFP variant of PRV, created by fusing the
gene encoding the capsid protein VP26 with the gene encoding GFP
(Smith et al., 2001), was kindly provided by G. Smith and L. Enquist.
Quantitative analysis of PRV entry in cells in adhesion
48 h post-seeding on a coverslip in a 24 well plate, swine kidney
(SK) cells were washed with RPMI medium and inoculated with the
VP26-GFP variant of PRV at a multiplicity of infection (moi) of 100 in
RPMI medium. Cells were incubated at 37 °C for 2 h to allow viral
entry, washed twice with PBS and thereafter, ﬁxation was performed
with 3% paraformaldehyde (PFA) in PBS. No permeabilization stepwas
performed. Virus at the outer side of the cell was stained with
biotinylated anti-PRV antibodies followed by Streptavidin-Texas Red.
After mounting in a glycerin–PBS solution (0.9:0.1, vol:vol) with 2.5%
1,4,-diazabicyclo(2.2.2)octane (Janssen Chimica, Beerse, Belgium)
(glycerin-DABCO), cells were analyzed using a TCS SP2 laser scanning
spectrum confocal system (Leica microsystems, GmbH, Heidelberg,
Germany). Series of 6 confocal sections were taken in a 1 μm area
within a cell, sequentially for the GFP (Argon 488 nm laserline) and
the Texas Red (Gre/Ne 543 nm laserline) spectrum. After merging both
images, the number of perinuclear virions (virions that only carried
the GFP label) in the 1 μm area of the cell was counted. 20 cells were
counted per experiment and 3 independent repeats of the experi-
ment were performed. Statistical analysis of the data was performed
with the SPSS software (SPSS Inc.). Geometric means of the number of
perinuclear virions counted per cell for the different treatments
were transformed and compared in an Anova and a Tamhane test.
Geometric means and the 95% conﬁdence interval are presented. To
analyze the composition of the inoculum, inoculum was dried on
APES-coated microscope slides, ﬁxed in 100% methanol and stained
for the gB viral envelope protein with mouse anti-gB monoclonal
antibody followed by goat-anti-mouse Texas Red.
Removal of plasma membrane cholesterol by MBCD treatment and
cholesterol replenishment
47 h after seeding on a coverslip in a 24 well plate, SK cells were
washedwith RPMImedium, treatedwith 10mMMBCD in RPMI for 1 h
at 37 °C and washed twice with PBS. Cholesterol was either or not
replenished by incubating cells with 0, 5 or 100 μg/ml cholesterol in
RPMImedium for 1 h at 37 °C. After 2washingswith PBS, a quantitative
entry assay was performed as described above.
Efﬁciency of cholesterol removal was assessed with the Amplex®
Red Cholesterol Assay Kit, according to the protocol provided by the
manufacturer, using a Fluoroskan Ascent FL ﬂuorometer (Thermo
Labsystems, Franklin, MA). Means and standard deviation of 3 inde-
pendent measurements are presented.
Quantitative analysis of PRV entry in cells in suspension
0.5⁎107 SK cells were suspended in 5ml RPMImediumor 5ml RPMI
medium with 10 mM MBCD, incubated for 1 h in a suspension tissue
culture ﬂask (Sarstedt, Nümbrecht, Germany) on a tilting platform at37 °C and washed with PBS. VP26-GFP PRV was added to the cells at a
moi of 50 and cells were incubated 2 h at 4 °C to allow virus attachment
or at 37 °C to allow virus entry. Cells were washed with ice-cold PBS,
ﬁxed with 3% PFA in PBS, permeabilized with 0.1% Triton X-100 in PBS
and stained with Phalloidin-Texas Red. After mounting on microscope
slideswith glycerin-DABCO, cellswere analyzed byconfocalmicroscopy.
Series of 6 confocal sections were taken in a 1 μm area within a cell,
sequentially for theGFP and the Texas Red spectrum. Aftermergingboth
images, virions in sectionsof 15 cellswere countedandwere classiﬁed as
being plasma membrane-associated (GFP virion signal contacts cortical
actin signal) or in the perinuclear zone. This experimentwas performed
3 times. Statistical analysis was performed with the SPSS software.
Meansand95%conﬁdence interval of the total numberof cell-associated
virions counted per cell and of the percentage of plasma membrane-
associated virions are presented.
Flow cytometric attachment assay
2⁎106 SK cells were suspended in either 1 ml RPMImedium or 1 ml
RPMI mediumwith 10 mMMBCD and incubated at 37 °C in suspension
on a tilting platform. Cellswerewashedwith PBS and incubated in RPMI
at 4 °C for 30 min. Thereafter, cells were inoculated 2 h at 4 °C with ice-
cold VP26-GFP PRV at amoi of 100 in ice-cold RPMI on a tilting platform
to allow virus attachment to the cell. After 2washingswith ice-cold PBS,
ﬂow cytometric analysis was performed with a FacsCanto (Becton
Dickinson). This experimentwasperformed3 times. To test speciﬁcityof
attachment, cells were pretreated with 250 μg/ml heparin in RPMI for
5 min at 37 °C. Cells were incubated at 4 °C for 30 min and attachment
was allowed as described above in the presence of 250 μg/ml heparin.
Trypsin treatment
SK cells in suspension were either or not treated with MBCD and
inoculated at 4 °C or 37 °C as described above for cells in suspension.
Thereafter, cells werewashedwith PBS and treated 5min at 37 °Cwith
10% trypsin stock solution and 1% EDTA stock solution in PBS to
remove virus on the cell surface. After washing them with PBS, cells
were ﬁxed with PFA, stained with Phalloidin-Texas Red and analyzed
by confocal microscopy as described above for cells in suspension. The
experiment was performed twice. The number of plasma membrane-
associated virions and of perinuclear virions was counted in MBCD-
treated cells that were either (12 cells) or not (12 cells) trypsin treated
after entry of the virus.
Co-localization of GM1 and VP26-GFP PRV virions during viral entry
In the experiments without pretreatment of the cells, SK cells in
suspensionwere inoculated at 37 °C on a tilting platformwithVP26-GFP
PRV at a moi of 50. 5 min p.i., cells were ﬁxed in 3% paraformaldehyde.
Cells were stained consecutively with biotinylated cholera toxin B
subunit and Streptavidin-Texas Red and mounted. Single confocal scans
were performed at the top region of the cell to assess co-localization of
VP26-GFP PRV virions and GM1.
In the experiments with GM1 patching before inoculation of the
cells, this was performed as described before (Harder et al., 1998), with
somemodiﬁcations. Brieﬂy, SK cellswere suspended inRPMIwith 10 μg/
ml biotin-labelled cholera toxin B subunit and incubated at 37 °C for
30min. Afterwashingwith PBS, cellswere further incubated at 37 °C for
30minwith 1/50 Streptavidin-TexasRed, inoculatedwithVP26-GFPPRV
at a moi of 50 for 5 min at 37 °C, ﬁxed in 3% paraformaldehyde and
mounted. Single confocal scans were performed at the top region of the
cell to assess co-localization of VP26-GFP PRV virions and GM1. At least
10 cells were analyzed per sample and virions on the scans were
classiﬁed as exactly co-localized with GM1 (coloc), contacting a GM1
region: juxtaposed (juxta), or not associated with GM1 (not assoc).
Control images with virus particles that were randomly positioned on
345A.S. Desplanques et al. / Virology 376 (2008) 339–345the cell, were constructed by merging unrelated images of PRV virions
and patched GM1. Real and control images weremixed andwere scored
blind by two researchers. The experiment was performed 3 times and
statistical analysis on the co-localization data was performed using the
SPSS software. Means of the percentage of virus particles per cell scan
thatwere coloc, juxta andnot assocwere compared for virus images and
control images in an Anova. Means and 95% conﬁdence interval are
presented.
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